Behnood Bikdeli, MD, MS
LightNews LightNews
bbikdeli.bsky.social
Behnood Bikdeli, MD, MS
@bbikdeli.bsky.social
74 followers 43 following 10 posts
Father, husband, cardiologist 🫀, investigator, #thrombosis, #antithrombotic therapy
Posts Replies Media Videos
bbikdeli.bsky.social
Global burden of #VTE: Unknown and underexplored for too long. Need concerted efforts to understand it. We summarize some 🗝️challenges and ways to address them in a @jaccjournals.bsky.social Viewpoint:

www.jacc.org/doi/10.1016/...
November 27, 2025 at 1:46 AM
Reposted by Behnood Bikdeli, MD, MS
markusathome.bsky.social
Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier

@bbikdeli.bsky.social

youtu.be/e0Orc_Ps56U?...
Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier
YouTube video by MARKUS at HOMe
youtu.be
November 21, 2025 at 7:39 PM
bbikdeli.bsky.social
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions | @jaccjournals.bsky.social www.jacc.org/doi/10.1016/...
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions
www.jacc.org
September 29, 2025 at 4:31 PM
Reposted by Behnood Bikdeli, MD, MS
scinews.bsky.social
This Review summarizes the diagnosis and treatment of Superficial vein thrombosis (SuVT).

jamanetwork.com/journals/jam...
September 18, 2025 at 3:32 PM
Reposted by Behnood Bikdeli, MD, MS
jama.com
Superficial vein thrombosis (SuVT) is characterized by thrombus in the superficial veins, typically in the lower or upper extremities.

This Review summarizes the diagnosis and treatment of SuVT.

ja.ma/4mlIxPL
Diagram from JAMA, Sept 15, 2025, titled "Superficial Vein Thrombosis: A Review." It shows common sites and pathophysiology of SuVT in upper and lower extremities, detailing vein names, thrombus formation, inflammation, and impeded blood flow.
September 15, 2025 at 4:15 PM
bbikdeli.bsky.social
Summary of the guideline recs for #anticoagulant & #antiplatelet therapy in ACS c/w prior recs in @americanheart.bsky.social @accintouch.bsky.social and @escardio.bsky.social guidelines. Thankful to Writing Committee & also a great team who made this summary possible:
www.jacc.org/doi/10.1016/...
June 4, 2025 at 12:53 AM
bbikdeli.bsky.social
Must do better for #PE risk stratification. In an @escardio.bsky.social
#EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great leadership by
#DavidJimenez @mmonrealriete.bsky.social
#RIETE! 👇:

tinyurl.com/trpmzbrd
May 24, 2025 at 4:49 PM
Reposted by Behnood Bikdeli, MD, MS
gbarnesmd.bsky.social
I often get asked if it’s safe to use #cvCoag mono therapy in patients with AF and stable CAD (i.e., PCI>6-12 months prior). @bbikdeli.bsky.social clearly shows safety and efficacy with OAC motherly in this population. #ACForum25
April 5, 2025 at 2:19 PM
Reposted by Behnood Bikdeli, MD, MS
anticoagpharmd.bsky.social
Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:...
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Redirecting
www.google.com
April 8, 2025 at 8:00 PM
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
📑Navigating Anticoagulation 💊 in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac 🫀MRI

Read Editorial by Ashkan Hashemi and @bbikdeli.bsky.social www.thieme-connect.de/products/ejo...

Original Article 📰 here www.thieme-connect.de/products/ejo...
April 28, 2025 at 9:50 AM
Reposted by Behnood Bikdeli, MD, MS
kencovinsky.bsky.social
Distressing account of how The FDA regulatory process failed patients
The Cook Celect IVC Filters: Failure to disclose serious harms including IVC rupture and death.
We must learn the lessons from this scandal
www.acpjournals.org/doi/10.7326/...
Information Disclosure, Medical Device Regulation, and Device Safety: The Case of Cook Celect IVC Filters | Annals of Internal Medicine
Although medical devices are widely used in clinical practice, clinicians and the public have limited access to information on how devices are tested, regulated, and used, posing challenges to patient...
www.acpjournals.org
January 12, 2025 at 4:26 PM
Reposted by Behnood Bikdeli, MD, MS
cardioobdoc.bsky.social
Anticoagulation & Antiplatelet Therapy for #AFib & Stable CAD:
Meta-Analysis of RCTs

#CardioSky #Epeeps #JACC
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @bbikdeli.bsky.social @mohammadkeykhaei.bsky.social @drroxmehran.bsky.social @gbarnesmd.bsky.social @cardiacpa1.medsky.social
February 11, 2025 at 10:04 PM
bbikdeli.bsky.social
For antithrombotic 💊 in AF+ACS/PCI:
-Many pts have recurrent ischemia or🩸.
-#AUGUSTUS results @dcrinews.bsky.social in @jaccjournals.bsky.social shows:

1.Apixaban ⬇️🩸c/w warfarin w/o ⬆️thrombosis
2. Placebo ⬇️🩸c/w aspirin w/o ⬆️thrombosis
Paper: tinyurl.com/2s4kuy8m
The Editorial: tinyurl.com/4evteweb
February 9, 2025 at 8:55 PM
Reposted by Behnood Bikdeli, MD, MS
cardioobdoc.bsky.social
Anticoagulation & Antiplatelet Therapy for #AFib & Stable CAD: Meta-analysis of RCTs

Will this finally change the practice?

#CardioSky #MedSky
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @bbikdeli.bsky.social @hmkyale.bsky.social @csilvers.bsky.social @load-dependent.bsky.social
January 21, 2025 at 9:35 PM
bbikdeli.bsky.social
😂😂Thank you so much @gbarnesmd.bsky.social for ur extremely kind words and for covering our study! Lots of credit to Sina for leading the effort, to the trial PIs who kindly helped w study-level unpublished data for certain outcomes/subgroups, and to team! 👏
gbarnesmd.bsky.social Geoffrey Barnes, MD, MSc @gbarnesmd.bsky.social · Jan 20
When does @bbikdeli.bsky.social sleep? I'm not sure - he's constantly publishing highly impactful work!! This week is no different. Check out this important meta-analysis on #cvCoag and #antiplatleet use in #AFib and stable #CAD! Less is more!!! @jaccjournals.bsky.social www.jacc.org/doi/10.1016/...
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials:
www.jacc.org
January 20, 2025 at 7:26 PM
Reposted by Behnood Bikdeli, MD, MS
middeldorps.bsky.social
Publication alert 📣! How to prevent #postpartum #VTE in women at moderate risk? Outcomes of the PILOTPARTUM pilot have been published in Lancet Hematology. Kudos to Dr Leslie Skeith and all passionate colleagues, and to all women who participated!
www.sciencedirect.com/science/arti...
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial
Despite the morbidity and mortality of venous thromboembolism, there is little evidence to guide postpartum thromboprophylaxis in patients at moderate…
www.sciencedirect.com
January 18, 2025 at 3:10 PM
bbikdeli.bsky.social
When pts have stable #CAD & #AF, do we need both #anticoagulant therapy and #antiplatelet agents? Our collaborative meta-analysis of RCTs shows that monotherapy with anticoagulation ⬇️🩸 without a large increase in ischemic events. @jaccjournals.bsky.social

www.jacc.org/doi/10.1016/...
January 19, 2025 at 4:00 PM
Reposted by Behnood Bikdeli, MD, MS
hmkyale.bsky.social
Happy holidays from @jaccjournals.bsky.social - we pride ourselves on speed and wisdom in making editorial decisions…and yet, our offices and editors will take a holiday break. We urge everyone to take some time to recharge. See you in 2025! www.youtube.com/watch?v=zYln...
JACC | Happy Holidays
YouTube video by American College of Cardiology
www.youtube.com
December 21, 2024 at 12:40 AM
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
💊 Direct Oral Anticoagulants: a quick primer on when to use ✅ and when to avoid ❌

Read on TH 👉 www.thieme-connect.com/products/ejo...

#HemSky #CardioSky
November 30, 2024 at 2:09 PM
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
📢🆓Effective immediately, Thrombosis and Haemostasis no longer imposes page and color charges for articles published in the journal!

We look forward to your submissions and hope this adjustment will facilitate a smoother publishing process!
December 2, 2024 at 2:32 PM
Reposted by Behnood Bikdeli, MD, MS
cardioobdoc.bsky.social
Sex differences in treatment strategies for pulmonary embolism in older adults: SERIOUS-PE study of RIETE participants & US Medicare beneficiaries

#CardioSky #MedSky
@bbikdeli.bsky.social @heatherlgornik.bsky.social @hmkyale.bsky.social
journals.sagepub.com/eprint/NPMGB...
November 28, 2024 at 2:20 AM